Course of menopause in women living with HIV

• Conditions: B24; Unspecified human immunodeficiency virus [HIV] disease

• Registration Number: DRKS00020924
• Lead Sponsor: niversitätsklinikum Frankfurt

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2020-02-06
• Study Start: 2022-11-09
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 194

Inclusion Criteria

HIV positive and HIV negative women between 45 and 60 years

Exclusion Criteria

No exclusion criteria

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Age of onset and course of menopause in women living with HIV. Determination of the severity of the symptoms using the score of the Menopause Rating Scale (MRS)

Secondary Outcome Measures

Name	Time	Method
• Clinical and laboratory chemical parameters<br>• Data on antiretroviral therapy<br>• Comparison of age at onset of menopause and course of perimenopause in HIV-positive and negative women